Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Systemic sclerosis

Genome-wide mutagenesis reported in systemic sclerosis

The mechanisms that drive the diverse disease manifestations and increased cancer risk associated with systemic sclerosis are unclear. Investigating the genomic alterations observed in patients with systemic sclerosis could contribute towards untangling this complex disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Genomic mutations in SSc fibroblasts could expose patients to an increased risk of cancer.

References

  1. Mecoli, C. A., Rosen, A., Casciola-Rosen, L. & Shah, A. A. Advances at the interface of cancer and systemic sclerosis. J. Scleroderma Relat. Disord. 6, 50–57 (2021).

    Article  PubMed  Google Scholar 

  2. Artlett, C. M., Black, C. M., Briggs, D. C., Stephens, C. & Welsh, K. I. DNA allelic alterations within VNTR loci of scleroderma families. Br. J. Rheumatol. 35, 1216–1222 (1996).

    Article  CAS  PubMed  Google Scholar 

  3. Artlett, C. M., Black, C. M., Briggs, D. C., Stevens, C. O. & Welsh, K. I. Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br. J. Rheumatol. 35, 732–737 (1996).

    Article  CAS  PubMed  Google Scholar 

  4. Vijayraghavan, S. et al. Widespread mutagenesis and chromosomal instability shape somatic genomes in systemic sclerosis. Nat. Commun. 15, 8889 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Torreggiani, S., Castellan, F. S., Aksentijevich, I. & Beck, D. B. Somatic mutations in autoinflammatory and autoimmune disease. Nat. Rev. Rheumatol. 20, 683–698 (2024).

    Article  PubMed  Google Scholar 

  6. Nonaka, T. et al. Involvement of activation-induced cytidine deaminase in skin cancer development. J. Clin. Invest. 126, 1367–1382 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Paul, S. et al. Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis. Nat. Commun. 13, 7074 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Artlett, C. M. et al. The inflammasome activating caspase-1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum. 63, 3563–3574 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. Wyman, A. E. & Atamas, S. P. Sirtuins and accelerated aging in scleroderma. Curr. Rheumatol. Rep. 20, 16 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yun, J. H. et al. Clonal somatic mutations in chronic lung diseases are associated with reduced lung function. Am. J. Respir. Crit. Care Med. 208, 1196–1205 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Varga.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Artlett, C.M., Varga, J. Genome-wide mutagenesis reported in systemic sclerosis. Nat Rev Rheumatol 21, 135–136 (2025). https://doi.org/10.1038/s41584-025-01219-8

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41584-025-01219-8

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing